Browsing by Author Menzies, Alexander

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 11 of 11
Issue DateTitleAuthor(s)Citation
201318F-labelled fluorodeoxyglucose-positron emission tomography (FDG-PET) heterogeneity of response is prognostic in dabrafenib treated BRAF mutant metastatic melanomaCarlino, Matteo; Haydu, Lauren; Kefford, Richard (Rick); Long, Georgina; Saunders, Catherine; Curtis, C. Martin; Lebowitz, Peter; Menzies, Alexander; Western Clinical School: Medicine (Westmead); Central Clinical School: Surgery; Western Clinical School: Westmead Millennium Institute; Central Clinical School: The Sydney Cancer Centre; Central Clinical School: Medicine18F-labelled fluorodeoxyglucose-positron emission tomography (FDG-PET) heterogeneity of response is prognostic in dabrafenib treated BRAF mutant metastatic melanoma, European Journal of Cancer, vol.49, 2, 2013,pp 395-402
2013BRAF inhibitor activity in V600R metastatic melanomaClements, Arthur; Kefford, Richard (Rick); Long, Georgina; O'Toole, Sandra; Klein, Oliver; Menzies, Alexander; Western Clinical School: Medicine (Westmead); Western Clinical School: Westmead Millennium Institute; Central Clinical School: The Sydney Cancer Centre; Central Clinical School: PathologyBRAF inhibitor activity in V600R metastatic melanoma, European Journal of Cancer, vol.49, 5, 2013,pp 1073-1079
2014BRAF inhibitor resistance mechanisms in metastatic melanoma: spectrum and clinical impactBecker, Therese; Boyd, Suzanah; Carlino, Matteo; Fung, Carina; Haydu, Lauren; Howle, Julie; Kefford, Richard (Rick); Long, Georgina; Mijatov, Branka; Pupo, Gulietta; Rizos, Helen; Saw, Robyn; Scolyer, Richard; Thompson, John; Hyman, Jessica; Menzies, Alexander; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Medicine (Westmead); Western Clinical School: Medicine (Westmead); Infectious Diseases; Central Clinical School: Surgery; Western Clinical School: Surgery; Western Clinical School: Westmead Millennium Institute; Central Clinical School: The Sydney Cancer Centre; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Medicine (Westmead); Western Clinical School: Westmead Millennium Institute; Central Clinical School: Surgery; Central Clinical School: Pathology; Central Clinical School: SurgeryBRAF inhibitor resistance mechanisms in metastatic melanoma: spectrum and clinical impact, Clinical Cancer Research, vol.20, 7, 2014,pp 1965-1977
2013BRAF(V600E) protein expression and outcome from BRAF inhibitor treatment in BRAF(V600E) metastatic melanomaHaydu, Lauren; Kefford, Richard (Rick); Long, Georgina; Menzies, Alexander; Scolyer, Richard; Thompson, John; Wilmott, James; Capper, D; Preusser, Matthias; von Diemling, Andreas Von; Zhang, Yuxiao; Central Clinical School: Surgery; Western Clinical School: Westmead Millennium Institute; Central Clinical School: The Sydney Cancer Centre; Central Clinical School: Medicine; Central Clinical School: Pathology; Central Clinical School: Surgery; Central Clinical School: SurgeryBRAF(V600E) protein expression and outcome from BRAF inhibitor treatment in BRAF(V600E) metastatic melanoma, British Journal of Cancer, vol.108, 4, 2013,pp 924-931
2012Dabrafenib and its potential for the treatment of metastatic melanomaLong, Georgina; Menzies, Alexander; Murali, Rajmohan; Central Clinical School: The Sydney Cancer CentreDabrafenib and its potential for the treatment of metastatic melanoma, Drug Design, Development and Therapy, vol.6, N/A, 2012,pp 391-405
2012Distinguishing Clinicopathologic Features of Patients with V600E and V600K BRAF-Mutant Metastatic MelanomaCarlino, Matteo; Haydu, Lauren; Howle, Julie; Kefford, Richard (Rick); Long, Georgina; Menzies, Alexander; Scolyer, Richard; Thompson, John; Visintin, Lydia; Western Clinical School: Medicine (Westmead); Central Clinical School: Surgery; Western Clinical School: Medicine (Westmead); Western Clinical School: Westmead Millennium Institute; Central Clinical School: The Sydney Cancer Centre; Central Clinical School: Medicine; Central Clinical School: Pathology; Central Clinical School: SurgeryDistinguishing Clinicopathologic Features of Patients with V600E and V600K BRAF-Mutant Metastatic Melanoma, Clinical Cancer Research, vol.18, 12, 2012,pp 3242-3249
2013MelanomaMenzies, Alexander; Thompson, John; Central Clinical School: Medicine; Central Clinical School: SurgeryMelanoma, Cancer Forum, vol.37, 1, 2013,pp 65-66
2013New combinations and immunotherapies for melanoma: latest evidence and clinical utilityLong, Georgina; Menzies, Alexander; Central Clinical School: The Sydney Cancer Centre; Central Clinical School: MedicineNew combinations and immunotherapies for melanoma: latest evidence and clinical utility, Therapeutic Advances in Medical Oncology, vol.5, 5, 2013,pp 278-285
2013Paradoxical oncogenesis: are all BRAF inhibitors equal?Kefford, Richard (Rick); Long, Georgina; Menzies, Alexander; Western Clinical School: Westmead Millennium Institute; Central Clinical School: The Sydney Cancer Centre; Central Clinical School: MedicineParadoxical oncogenesis: are all BRAF inhibitors equal?, Pigment Cell and Melanoma Research, vol.26, 5, 2013,pp 611-615
2011Prognostic and Clinicopathologic Associations of Oncogenic BRAF in Metastatic MelanomaHamilton, Anne; Haydu, Lauren; Hughes, Thomas; Kefford, Richard (Rick); Long, Georgina; Mann, Graham; Scolyer, Richard; Thompson, John; Menzies, Alexander; Nagrial, Adnan; Central Clinical School: Medicine; Central Clinical School: Surgery; Melanoma Foundation; Western Clinical School: Westmead Millennium Institute; Central Clinical School: The Sydney Cancer Centre; Western Clinical School: Westmead Millennium Institute; Central Clinical School: Pathology; Central Clinical School: SurgeryPrognostic and Clinicopathologic Associations of Oncogenic BRAF in Metastatic Melanoma, Journal of Clinical Oncology, vol.29, 10, 2011,pp 1239-1246
2013Recent advances in melanoma systemic therapy. BRAF inhibitors, CTLA4 antibodies and beyondLong, Georgina; Menzies, Alexander; Central Clinical School: The Sydney Cancer Centre; Central Clinical School: MedicineRecent advances in melanoma systemic therapy. BRAF inhibitors, CTLA4 antibodies and beyond, European Journal of Cancer, vol.49, 15, 2013,pp 3229-3241